News >

Breakthrough Therapies Enrich Evolving CLL Paradigm

Caroline Seymour
Published: Thursday, Sep 19, 2019

Herbert A. Eradat, MD, associate professor, University of California, Los Angeles Medical Center

Herbert A. Eradat, MD

Novel therapies and clinical trial designs are steering chronic lymphocytic leukemia (CLL) treatment away from cytotoxic chemotherapy and toward a paradigm of alleviated clinical and financial burden, explained Herbert A. Eradat, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication